VAERS reports by lot

Pfizer COVID-19 lot EL1685: VAERS reports

26 VAERS reports list lot EL1685 as a Pfizer COVID-19 vaccine, received between 2020-12-28 and 2022-03-05. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
26
Reports
8%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular2826%
Gastrointestinal2018%
General / Systemic (non-local)1917%
Neurological1413%
Dermatological (non-injection-site)76%
Thrombotic / Hematological66%
Respiratory44%
Musculoskeletal44%
Injection-site / Local reaction33%
Allergic / Anaphylactic22%
Reproductive / Menstrual22%

Where reports came from

U.S. state of the reporter, where given (top 9).

New York10
California3
Ohio3
Pennsylvania1
Michigan1
Oklahoma1
Arkansas1
Connecticut1
New Jersey1

Reports by month received

2020-122
2021-014
2021-0314
2021-041
2021-051
2021-071
2021-081
2022-011
2022-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.